[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$frkmWVHdC1VNB8aZPEwH20Lyf_e-G1Z9aSpt0ffsELLw":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":32,"rows":39},"Universitätsklinikum Köln",[4],33,false,2,1,10473,0,29,[14,17,19,21,23,25,27,29],{"name":15,"count":16},"Ventricular Tachycardia",3,{"name":18,"count":8},"Multiple Trauma",{"name":20,"count":8},"Atrial Arrhythmia",{"name":22,"count":8},"Implantable Defibrillator User",{"name":24,"count":8},"PVC - Premature Ventricular Complex",{"name":26,"count":8},"Heart Failure",{"name":28,"count":8},"ICD Malfunction",{"name":30,"count":8},"Cardiac Arrest",[],[33,34,35,36,37,38],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[40,67,94,112,137],{"intervention":41,"totalTrials":9,"cells":42},"5-fluorouracil and low molecular weight heparin",{"EARLY_PHASE1":43,"PHASE1":45,"PHASE2":47,"PHASE3":49,"PHASE4":63,"NA":65},{"trials":44,"activeCount":11},[],{"trials":46,"activeCount":11},[],{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[51],{"nctId":52,"briefTitle":53,"status":54,"phases":55,"primaryCompletion":56,"completion":56,"start":57,"enrollment":58,"conditions":59,"interventions":62},"NCT02834559","Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.","COMPLETED",[36],"2020-06-15","2016-10-27",326,[60,61],"Rhegmatogenous Retinal Detachment","High-risk for Proliferative Vitreoretinopathy (PVR)",[41],{"trials":64,"activeCount":11},[],{"trials":66,"activeCount":11},[],{"intervention":68,"totalTrials":9,"cells":69},"Pre-Chemo-radio-immunotherapy Treatment",{"EARLY_PHASE1":70,"PHASE1":72,"PHASE2":74,"PHASE3":88,"PHASE4":90,"NA":92},{"trials":71,"activeCount":11},[],{"trials":73,"activeCount":11},[],{"trials":75,"activeCount":11},[76],{"nctId":77,"briefTitle":78,"status":79,"phases":80,"primaryCompletion":81,"completion":82,"start":83,"enrollment":11,"conditions":84,"interventions":86},"NCT05504642","Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients","WITHDRAWN",[35],"2026-06","2026-07","2023-11-01",[85],"Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases",[68,87],"Concurrent Chemo-radio-immunotherapy",{"trials":89,"activeCount":11},[],{"trials":91,"activeCount":11},[],{"trials":93,"activeCount":11},[],{"intervention":87,"totalTrials":9,"cells":95},{"EARLY_PHASE1":96,"PHASE1":98,"PHASE2":100,"PHASE3":106,"PHASE4":108,"NA":110},{"trials":97,"activeCount":11},[],{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[102],{"nctId":77,"briefTitle":78,"status":79,"phases":103,"primaryCompletion":81,"completion":82,"start":83,"enrollment":11,"conditions":104,"interventions":105},[35],[85],[68,87],{"trials":107,"activeCount":11},[],{"trials":109,"activeCount":11},[],{"trials":111,"activeCount":11},[],{"intervention":113,"totalTrials":9,"cells":114},"human SARS-CoV 2 specific T lymphocytes",{"EARLY_PHASE1":115,"PHASE1":117,"PHASE2":129,"PHASE3":131,"PHASE4":133,"NA":135},{"trials":116,"activeCount":11},[],{"trials":118,"activeCount":11},[119],{"nctId":120,"briefTitle":121,"status":122,"phases":123,"primaryCompletion":124,"completion":124,"start":125,"enrollment":9,"conditions":126,"interventions":128},"NCT04762186","Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19","TERMINATED",[34],"2022-08-03","2021-12-08",[127],"Moderate COVID-19-infection",[113],{"trials":130,"activeCount":11},[],{"trials":132,"activeCount":11},[],{"trials":134,"activeCount":11},[],{"trials":136,"activeCount":11},[],{"intervention":138,"totalTrials":9,"cells":139},"Intensified medical therapy",{"EARLY_PHASE1":140,"PHASE1":142,"PHASE2":144,"PHASE3":146,"PHASE4":148,"NA":150},{"trials":141,"activeCount":11},[],{"trials":143,"activeCount":11},[],{"trials":145,"activeCount":11},[],{"trials":147,"activeCount":11},[],{"trials":149,"activeCount":11},[],{"trials":151,"activeCount":11},[152],{"nctId":153,"briefTitle":154,"status":54,"phases":155,"primaryCompletion":156,"completion":156,"start":157,"enrollment":158,"conditions":159,"interventions":164},"NCT04065893","Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy",[],"2021-08-01","2020-09-01",65,[160,161,15,162,163],"Systolic Heart Failure","Ventricular Premature Complexes","Cardiac Resynchronization Therapy","Reduced Biventricular Pacing",[138]]